Align glycerate 2-kinase (EC 2.7.1.165) (characterized)
to candidate 8502088 DvMF_2801 Hydroxypyruvate reductase (RefSeq)
Query= BRENDA::O58231 (440 letters) >FitnessBrowser__Miya:8502088 Length = 452 Score = 298 bits (762), Expect = 3e-85 Identities = 184/442 (41%), Positives = 260/442 (58%), Gaps = 19/442 (4%) Query: 13 LVGEAIKAADPYRAVLNAVKVSDDKIIVQGKEFEIKG--KVYVIALGKAACEMARAIEDI 70 ++ A+ A P RAV V+ + + + + G+++++ +VYV+ GK A MA A+EDI Sbjct: 12 ILSRALDAVAPDRAVHRHVRRNGNILHIAGRDYDLSAHERVYVVGAGKGAAPMAAALEDI 71 Query: 71 LD--VEDGVAVTKYGYGKELKRIKVIEAGHPIPDEKSILGAKEALSILNRARENDIVFIL 128 L V DGV V KYG+ LKRI + EA HP+PD A E L ++ A D+V Sbjct: 72 LGDRVHDGVVVVKYGHTAPLKRIALREAAHPVPDAAGERAANEILDLVRTAGPRDLVLCA 131 Query: 129 ISGGGSALFELPEEGISLEDLKLTTDLLLKSGAKIHEINTVRKHISKVKGGKLAKMIKGT 188 ++GG SAL + GI+L+D++ T LLL+ GA IHEIN +RKH+S GG LA+ Sbjct: 132 LTGGASALTPALQPGITLDDMRAATTLLLECGATIHEINALRKHLSAFGGGNLARAAAPA 191 Query: 189 GIV-LIISDVVGDNLEAIASGPTVKDPTTFEDAKRILELYDIWEKVPESVRLHIERGLRG 247 +V LIISDVVGD+L+ IASGPT D +T+ D K I + I ++PE V + GLRG Sbjct: 192 RVVSLIISDVVGDDLDVIASGPTSPDVSTYADCKSIAYRFGILHRLPEPVVERLTAGLRG 251 Query: 248 EVEETLKEDLP---NVHNFLIASNSISCEAIAREAQRLGFKAYIMTTTLEGEAKDAGLFI 304 ET K P V N ++ASN ++ EA A A G++ I+T T+ GEA+ + Sbjct: 252 MAAETPKPGDPVFGAVQNCIVASNRLALEAAAEAAAAHGYRPRILTDTMTGEAR---VRA 308 Query: 305 GSIVQEIAE--RGRPF-EPPVVLVFGGETTVTIEGKGGKGGPNQEIALSATRKISDL--- 358 +V+E A G P E P L+ GGETTVTI G GG GG NQE+AL+A ++ +L Sbjct: 309 RELVEEAASAAEGLPHPEGPFCLLAGGETTVTITG-GGLGGRNQEMALAAAIRMDELADC 367 Query: 359 -EALIVAFDTDGTDGPTDAAGGIVDGTTYKKLREKGIDVEKVLKEHNSYEALKKVGGLLF 417 ++ TDGTDGPTDAAGG G+T R+ G+D L ++++Y L + G LL Sbjct: 368 QHIAMLCAGTDGTDGPTDAAGGYASGSTLCVARQCGVDAHGHLADNDAYHFLDRTGHLLR 427 Query: 418 TGPTGTNVNSIVIAIVTSKRGR 439 TGPT TNV + + +V + +G+ Sbjct: 428 TGPTLTNVMDLAVLLVDAPKGK 449 Lambda K H 0.315 0.137 0.376 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 449 Number of extensions: 22 Number of successful extensions: 7 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 440 Length of database: 452 Length adjustment: 32 Effective length of query: 408 Effective length of database: 420 Effective search space: 171360 Effective search space used: 171360 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 42 (22.0 bits) S2: 51 (24.3 bits)
This GapMind analysis is from Sep 17 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory